• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Radiol . Chest radiography predictor of COVID-19 adverse outcomes. A lesson learnt from the first wave

tetano

Editor, Senior Moderator
Clin Radiol


. 2021 Mar 31;S0009-9260(21)00194-X.
doi: 10.1016/j.crad.2021.03.011. Online ahead of print.
Chest radiography predictor of COVID-19 adverse outcomes. A lesson learnt from the first wave


N Flor[SUP] 1 [/SUP], G Casazza[SUP] 2 [/SUP], L Saggiante[SUP] 3 [/SUP], A P Savoldi[SUP] 3 [/SUP], R Vitale[SUP] 3 [/SUP], P Villa[SUP] 4 [/SUP], F Martucci[SUP] 4 [/SUP], E Ballone[SUP] 5 [/SUP], A Castelli[SUP] 5 [/SUP], A M Brambilla[SUP] 4 [/SUP]



Affiliations

Abstract

Aim: To assess the role of a severity score based on chest radiography (CXR) in predicting the risk of adverse outcomes in coronavirus disease 2019 (COVID-19).
Materials and methods: Of the patients who presented to L. Sacco Hospital (Milan, Italy) between 21 February and 31 March 2020, patients with a laboratory confirmation of COVID-19 who also underwent a CXR were included in the study. To quantify the extent of lung involvement, each CXR image was given a score (Milan score), ranging from 0 to 24, depending on the presence of reticular pattern and/or ground-glass opacities and/or extensive consolidations in each of the 12 areas in which the lungs were divided. The score was calculated by an expert radiologist, blinded to laboratory tests. The ability of the Milan score to predict hospital admission and mortality, after adjusting for some variables (age; gender; comorbidities; time between symptoms onset and admission), using univariate and multivariate statistical analysis was investigated retrospectively.
Results: Among the 554 patients, 115 of which (21%) had a negative CXR, the in-hospital mortality was 16% (90/554). At univariate analysis, age, gender, and comorbidities were significant predictors of mortality and hospital admission. At multivariate analysis, adjusting for age and gender, the Milan score was an independent predictor of mortality and hospitalisation. In particular, patients with a Milan score ? 9 had a mortality risk five-times higher than those with a lower score. Other independent predictors of mortality were gender and age.
Conclusions: The CXR Milan score was an independent predictive factor of both in-hospital mortality and hospital admission.
 
Back
Top Bottom